N/A
Completed N=38
Non-Invasive Brain Stimulation and Substance Use
Source: ClinicalTrials.gov NCT03122587 ↗Enrolled (actual)
38
Serious AEs
0.0%
Results posted
Mar 2020
Primary outcomePrimary: Change in Distress Tolerance (Mean Latency to Quit the PASAT-C) — 11.2; 9.8; 9.4 minutes
Summary
The will investigate the feasibility and effectiveness and initial efficacy of non-invasive transcranial alternating current stimulation (tACS) on distress tolerance and inhibitory control among treatment seeking substance users.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Distress Tolerance (Mean Latency to Quit the PASAT-C) |
11.2; 9.8; 9.4 | — |
| PRIMARY Change in Inhibitory Control (Mean D-prime on the Go/No-Go) |
-0.6; 0.9; -0.3 | — |
Eligibility Criteria
Inclusion Criteria
- Current Diagnostic and Statistical Manual of Mental Disorders (DSM-V) Substance Use Disorder
- Current smoker
- Abstinent from all substances (except nicotine) for at least the past 2 weeks
Exclusion Criteria
- Current use of antiepileptic drugs and/or benzodiazepines
- Less than 6 months since an electroconvulsive therapy (ECT) session
- Current DSM-V Psychotic Disorder
- Pregnancy and/or nursing
- Ongoing or history of traumatic brain injury (TBI), reoccurring seizures, stroke, or brain tumors
- Medical or neurological illness
- Brain devices and/or implants
Data sourced from ClinicalTrials.gov (NCT03122587). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.